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Abstract.  Analysis of MM14 mouse myoblasts demon- 
strates that terminal differentiation is repressed by pure 
preparations of both acidic and basic fibroblast growth 
factor (FGF). Basic FGF is ~30-fold more potent than 
acidic FGF and it exhibits half maximal activity in 
clonal assays at 0.03  ng/ml (2 pM).  FGF repression 
occurs only during the G~ phase of the cell cycle by a 
mechanism that appears to be independent of ongoing 
cell proliferation. When exponentially growing myo- 
blasts are deprived of FGF, cells become postmitotic 
within 2-3 h, express muscle-specific proteins within 
6-7 h, and commence fusion within 12-14 h. Although 
expression of these three terminal differentiation 
phenotypes occurs at different times, all are initiated 
by a  single regulatory "commitment" event in G~. The 
entire population commits to terminal differentiation 
within 12.5  h  of FGF removal as all cells complete the 
cell cycle and move into Gt.  Differentiation does not 
require a new round of DNA synthesis. Comparison of 
MM14 behavior with other myoblast types suggests a 
general model for skeletal muscle development in 
which specific growth factors serve the dual role of 
stimulating myoblast proliferation and directly repress- 
ing terminal differentiation. 
S 
KE  L  Ea"A  L muscle development involves an initial period 
of myoblast replication, followed by a phase in which 
some myoblasts continue to proliferate while others un- 
dergo terminal differentiation. The latter process  involves 
the permanent cessation of DNA  synthesis, activation of 
muscle-specific gene expression, and the fusion of single 
cells into multinucleated muscle fibers. In vitro studies indi- 
cate that the onset of terminal differentiation is delayed by 
media that are rich in serum and/or embryo extract compo- 
nents (3,  15, 21, 22, 27, 28,  33,  37, 40, 42); and there is a 
general consensus that this is due to the influence of growth 
factors. Studies from our laboratory with a permanent skele- 
tal muscle line derived from a mouse muscle satellite cell 
(MM14), indicated that the critical component in embryo ex- 
tract was probably fibroblast growth factor (FGF)  I (27, 28). 
However,  since the FGF preparations available at that time 
were <1% pure, and since several forms of FGF were thought 
to exist, the role of FGF remained ambiguous. Subsequent 
studies of BC3H1 muscle cells have corroborated the role of 
FGF in repressing muscle differentiation (23, 24). However, 
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1. Abbreviations  used in this paper: AChR, acetylcholine receptor; FIOC, 
Ham's F10 nutrient medium plus 0.8 mM additional CaCI2; FGF, fibroblast 
growth factor;  a-FGF,  b-FGF,  acidic and basic forms of FGF;  [3H]Tdr, 
tritium-labeled thymidine, HS, horse serum; MHC, myosin heavy chain. 
since BC3H1 cells may be of smooth muscle origin (i.e., the 
line was derived from a chemically induced mouse brain tu- 
mor and does not exhibit either the fusion or postmitotic 
skeletal muscle phenotypes), it is not certain that BC3H1 be- 
havior can be extrapolated directly to the behavior of skeletal 
muscle cells. 
While it is generally agreed that the absence of mitogenic 
components triggers the onset of skeletal muscle differentia- 
tion, the subsequent developmental events are controversial. 
Some studies indicate that mitogen-deprived myoblasts irre- 
versibly lose their proliferative capacity (become postmi- 
totic) and activate muscle gene expression before fusion (3, 
27, 33, 40, 42), thus suggesting that mitogens play a direct 
role as repressors of  an initial step in terminal differentiation. 
Other  studies  involving fusion-blocked cells  concur  that 
mitogen deprivation induces (derepresses) muscle gene ex- 
pression, but suggest that a second phenotype, the postmi- 
totic state, is not acquired without cell fusion (8, 12, 32). In 
the quail system, mitogen depletion is thought to regulate 
differentiation only indirectly by allowing cells to accumu- 
late in an extended G1  or Go phase,  presumably the only 
cell cycle period in which muscle-specific genes can be acti- 
vated and in which myocytes can fuse. An event after fusion 
is then presumed to block further mitogenic responsiveness. 
To gain further insight as to how mitogens regulate skeletal 
muscle differentiation we have continued an analysis of the 
MM14 mouse myoblast line. In the following experiments we 
demonstrate that picomolar levels of both acidic and basic 
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Figure 1.  Dose  response  of MM14 myoblasts to a- and  b-FGF. 
Clonal cultures were established in 60-mm dishes and grown for 
37 h in 4 ml F10C +  15 % HS containing various concentrations of 
pure a- and b-bovine  FGE  Cultures  were then  fixed, immuno- 
stained for MHC, and 40-90 colonies per FGF concentration were 
counted and assessed for MHC-negative cells. (A) Growth response 
to acidic and basic FGF: (e) a-FGF; (o) b-FGE Ordinate repre- 
sents the mean number of population doublings starting from one- 
cell clones. In the absence of FGF virtually all cells form two-cell 
colonies and thus complete one population  doubling.  Error bars 
represent one standard deviation. (B) Differentiation-repression re- 
sponse  to  a-  and  b-FGE  Ordinate  represents  the  total  MHC- 
negative  cells  (cells  that  fall  to  differentiate)/(total  cells  in  all 
clones)  x  100%.  Each data point represents several hundred total 
cells counted. 
FGF directly regulate muscle differentiation by repressing a 
G~-specific "commitment" event that directs  expression of 
the muscle phenotype. 
Materials and Methods 
Cell Cultures and Culture Media 
The MM14 line was derived by serial subcloning of myoblasts isolated from 
leg muscle of a 60-d-old male BALB/c mouse (16, 28). Cells used in these 
experiments were a  near tetraploid subline designated MM14DZ.  Unless 
stated otherwise, clonal cultures were established by plating 100-125 cells 
per 60-mm plate, feeding them once at 48 h, and then varying the media 
at 60 h. At the 60-h switch this protocol yields plates with ,'050 clones con- 
taining 16-32 cells. The experiments were performed at low clonal den- 
sity and with small colonies to avoid rapid depletion of  added growth factors 
(28). With this protocol, all cells were growing exponentially with a 12.5-h 
cell cycle at the time of the media switches (see below). Mitotic myoblasts 
were collected by rocking proliferating cultures several times and withdraw- 
ing the medium. The medium was centrifuged, and the cells were resus- 
pended and plated in cloning cylinders (5 ram) placed in the center of the 
dish.  1 h later, the cylinders were removed and the dishes were rocked to 
displace unattached cells from the original area of plating. Media switches 
were performed by rinsing plates twice with 2 ml Ham's F10e (Ham's F10 
supplemented with 0.8 mM CaCl2)  and then feeding cultures 3 ml of ex- 
perimental medium that was prcequilibrated to the proper pH and tempera- 
ture. The standard growth medium (mitogen-rich) consisted of Ham's Floe 
plus 1% antibiotics (10,000 U/ml penicillin G, 0.5 mg/ml streptomycin sul- 
fate), 15 % horse serum (15 % HS), and 3 % embryo extract. An alternative 
growth medium contained FGF instead of  embryo extract. FGF was initially 
purchased from Collaborative Research, Inc. (Waltham, MA) and handled 
as previously described (28). More recently the acidic (a-) and basic (b-) 
forms of  FGF obtained from bovine brain have been purified to homogeneity 
by heparin affinity chromatography (4,  29,  36);  these were active at <1 
ng/ml. Low mitogen (differentiation) media were made without embryo ex- 
tract or FGF and consisted of Floe, antibiotics, 1 gM insulin (which pre- 
vents rapid myotube degeneration in the absence of serum), and 0-15 % HS. 
Assays 
S-Phase  Cells. Cultures  were  pulse-labeled 30  min  with  3-5  gCi/ml 
[3H]thymidine ([aH]Tdr),  rinsed with saline, fixed in 70% ethanol, and air 
dried. Plates were coated with Kodak NT-B2 emulsion (diluted 3:2 with wa- 
ter), exposed 1-2 wk at 4°C, and developed with Microdol-X. 
Postmitotic Cells. Postmitotic cells were detected by their inability to in- 
corporate  [3H]Tdr  in the presence of mitogen-rich medium.  This assay 
consisted of refeeding cultures that had been deprived of FGF for various 
intervals with mitogen-rich medium and then, 12 h later, adding [3H]Tdr 
(0.3  gCi/ml),  and incubating an additional  18-30 h.  [3H]Tdr was added 
12 h after mitogan restoration to prevent the labeling of cells that had not 
completed S phase during mitogen deprivation (see Fig. 5). To calculate the 
percentage of postmitotic cells at the time that colonies were re,  exposed to 
mitogen rich medium, the average number of unlabeled cells per clone in 
cultures refed at time t (and fixed about 30 h later) was divided by the aver- 
age cell number per colony in parallel cultures fixed at time t.  Loss of 
colony-forming ability was measured by dissociating cultures at various 
times after mitogen withdrawal, replating known cell numbers at clonai den- 
sities in mitogen-rich medium, and then counting the number of macro- 
scopic colonies 4 d later.  The percentage of loss in colony formation was 
then calculated by comparison with the percentage of colony formation in 
cultures assayed just before mitogen deprivation. 
Myosin Heavy Chain (MHC). Cultures were rinsed with PBS, fixed with 
70%  ethanol/formalin/glacial acetic acid (20:2:1)  at 4°C for 1 min, and 
stored at 4°C in PBS. MHC was detected with the MF20 monoclonal anti- 
body (2),  kindly provided by Drs.  D.  Bader and D.  Fischman (Cornell 
University Medical College). MF20 culture medium was diluted 1:40 with 
1%  HS in 0.05 M Tris-saline pH 7.4.  The diluted antibody was added to 
culture plates (0.5 ml) for 1 h. Plates were rinsed, then stained using a bin- 
tinylated rabbit anti-mouse IgG, avidin, and biotinylated horseradish perox- 
idase orocednre (Vector Laboratories, Inc., Burlingame, CA). 
Acetylcholine Receptor (AChR). AChR-positive cells were detected au- 
toradiographieally via [12Sl]-labeled a-bungarotoxin binding as described 
previously (26). 
Results 
FGF-specific  Regulation of  Mouse Myogenesis 
Fig.  1 compares the ability of pure acidic (a-) and basic (b-) 
forms of FGF to stimulate myoblast proliferation and to re- 
press terminal differentiation. Myoblasts that had been grow- 
ing exponentially in medium containing 6 ng/ml FGF (ap- 
proximately a  1:1  ratio of a- and b-FGF) were replated in 
F10C  +  15 %  HS plus  increasing concentrations  of either 
type of FGE 37 h later (an interval during which log-phase 
myoblasts could undergo a maximum of three doublings, see 
below), the colonies were counted to determine the average 
population doublings per clone (Fig. 1 A) and the percentage 
of MHC-negative ("undifferentiated") cells in the entire pop- 
ulation (Fig. 1 B). The results support the following conclu- 
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Figure 2. FGF regulation of MM14 cell replication. Clonal cultures 
of MMI4 cells were grown exponentially for 60 h in FM (F10C + 
15 % HS + FGF), then rinsed twice with F10C, and refed with FM 
(n), or switched to FGF-minus media; (o) FIOC + 5 % HS, or (e) 
F10C +  15% HS. At the indicated times, cultures were labeled for 
30 rain with [3H]Tdr  and then fixed. After autoradiography, clones 
were scored for the total cell number and for the percentage of 
[3H]Tdr-positive  cells (cells in S phase). (,4) Effect of FGF remov- 
al on the percentage of S phase cells per clone. The dashed line 
represents the predicted decline in S phase cells if after 2 h of FGF 
depletion all post-Gt cells complete the cycle they are in at the 
normal rate but cells in Gl fail to initiate DNA synthesis (see tex0. 
(Inset) Cell cycle parameters determined for exponentially growing 
MMI4 cells (27). (B) Effect of FGF removal on the clonal growth 
rate. The dashed line represents the theoretical 12.5-h growth rate 
previously determined (27). Each data point represents an average 
from three experiments  (30  clones/point/experiment;  total,  90 
clones, and >3,000 cells per point). FGF levels in different experi- 
ments were 10--25 ng/ml (Collaborative Research, Inc.). 
sions:  (a) FGF is, indeed, a critical factor for stimulating 
myoblast growth and for repressing differentiation, i.e., in 
media with 15 % serum alone, no new cell cycles were initi- 
ated and all cells became myosin positive; (b) b-FGF is 30- 
fold more potent than a-FGF with respect to maintaining the 
myoblast, proliferative state; and (c) the dose response to 
each  FGF  type  is  virtually  identical  for  stimulating  cell 
proliferation and repressing terminal differentiation. Thus, 
the two processes are probably controlled by the same initial 
FGF-receptor interaction. 
The FGF dose-response data shown in Fig.  1 were ob- 
tained in media containing 15 % HS. In the absence of serum, 
FGF  fails  to  stimulate  proliferation,  but  it  does  repress 
differentiation (see below). Although maximal clonal growth 
rates are obtained in FGF-supplemented media containing 
15 %  HS,  this serum concentration is not required.  In the 
presence of high FGF the serum level can be reduced to 
1-2 % without the cessation of growth; but our attempts and 
those of others (17) to replace serum with epidermal growth 
factor, nerve growth factor, platelet-derived growth factor, 
insulin, insulin-like growth factor 1, transferrin, and fibro- 
nectin alone or in combination have been unsuccessful. Se- 
rum  is  not,  however,  required  for  MM14  differentiation. 
Cultures  switched to FIOC alone do not exhibit "normal" 
morphology, but they do exhibit "normal" differentiation as 
judged by the appearance of MHC-positive cells. The subse- 
quent studies of clonal growth were thus all performed with 
medium containing 15 % HS, while the studies of differentia- 
tion kinetics were performed in FGF-free media containing 
5 or 15 % HS. 5 % HS was used because it supported rapid 
differentiation kinetics which were more easily correlated 
with the cell cycle kinetics of MM14 cells. Data from differ- 
entiating cultures switched to F10C  +  15 % HS are included 
because they represent the single-variable control for FGF 
deprivation. 
Myoblasts Exposed to an FG  F-Deficient Environment 
Stop Cycling after Completing Mitosis 
To determine how FGF deprivation affects the myoblast cell 
cycle, DNA synthesis and clonal growth rate were monitored 
in cultures that had been switched to FGF-free media. For 
the first 2-3 h the percentage of cells in S phase remains con- 
stant (Fig. 2 A) and growth remains exponential (Fig. 2 B). 
After this lag period, however, the S-phase population de- 
clines and approaches zero over the next 8 h. The overall 
clonal growth rate during this interval remains exponential. 
This suggests that soon after FGF removal myoblasts stop en- 
tering S phase, while cells in S complete DNA synthesis and 
traverse G2 and mitosis at the normal rate;  the decline in 
S-phase cells approximates the 7.5-h length of S (Fig. 2 A, 
inset).  The conclusion that  the  FGF-deprived population 
withdraws into a G1 (or Go) compartment is based on the ob- 
servation that clones undergo an exact doubling at the maxi- 
mum rate before DNA synthesis and growth stop (Fig. 2 B). 
These  results  demonstrate  that  FGF  is  specifically re- 
quired for the initiation of new MM14 cell cycles. In a statisti- 
cal sense, the last G1 cell to enter S phase 2-3 h after FGF 
removal is the last cell to divide at 13-14 h when the clone 
finally stops growing. We have compared this model of myo- 
blast behavior to a mathematical cell cycle model that spec- 
ifies the distribution of cells through the cycle (37, 41). The 
theoretical decline in S-phase cells after FGF removal close- 
ly resembles the experimental results (Fig. 2 A, dashed line). 
FGF-deprived Myoblasts Express Muscle-specific 
Proteins before Fusing 
After  FGF  removal,  MHC-positive  cells  are  detected  in 
clones at 7-8 h (~5 h after cells begin to withdraw from the 
cell cycle) and fusion is first observed at 12-16 h (Fig. 3). Af- 
ter 18 h in 5 % HS, 96 % of the cells contained MHC protein, 
while only 30 % of the nuclei appeared in myotubes. Thus, 
nearly all cells had withdrawn from the cell cycle (Fig. 2) and 
had become MHC positive at a time when relatively few cells 
had fused. Additional experiments have shown that the mus- 
Clegg et al. FGF Control of Skeletal Muscle Differentiation  951 s 
o 
o 
o  2o 
:E 
0 
100 
9 
o 
~  4o 
~  2o 
0 
lOO 
A 
8O 
60 
40 
4  8  12  16  20  24 
HOURS  AFTER  FGF  REMOVAL 
t  t  I  I  l  I 
B 
4  8  12  16  20  24 
HOURS AFTER  FGF  REMOVAL 
Figure 3. Kinetics of muscle- 
specific protein accumulation 
and fusion after FGF depriva- 
tion.  Clonal  MM14 cultures 
were grown exponentially for 
3  d,  then  rinsed  twice  with 
F10C, and refed with FIOC + 
15%  HS  +  FGF  ([]),  or 
switched to FGF-minus media 
(o) F10C + 5% HS; (e) F10C 
+  15 % HS. At the indicated 
times cultures  were fixed for 
MHC  and  fusion  detection. 
(A) Percentage of MHC-posi- 
tive cells per clone.  (B) Per- 
cent myotube nuclei per clone. 
For a colony to be scored as 
fused, it had to contain at least 
two multinucleated cells with 
a  minimum  of three  nuclei/ 
cell.  Each  data  point  repre- 
sents an average from three ex- 
periments  (90 clones,  >3,000 
total cells per point). FGF lev- 
els  in  different  experiments 
were 10-25 ng/ml (Collabora- 
tive Research,  Inc.). 
cle forms of creatine kinase (6) and actin (5) also appear be- 
fore MM14 fusion with the same kinetics as MHC. The onset 
of MHC accumulation,  and the final percentage of MHC- 
positive cells, differed in clones as a function of serum con- 
centration.  Cultures switched to F10C  +  15 % HS behaved 
similarly except that fewer cells became MHC positive by 
24 h and the percentage of nuclei in myotubes was somewhat 
lower. 
Myoblasts Commit to Terminal Differentiation  within 
2 h of  FGFDeprivation 
FGF deprivation induces  MM14  myoblasts to begin with- 
drawing from the cell cycle within 2-3 h, to begin accumulat- 
ing detectable levels of MHC by 7-8 h, and to begin fusing 
by 12-14 h. When do these phenotypes become irreversibly 
activated (i.e., when do cells become "committed" to termi- 
nal  differentiation)?  Although  the  mechanism of commit- 
ment is not understood, the process can be delineated by de- 
termining the duration of FGF deprivation required before 
its restoration no longer represses the onset of differentia- 
tion. Log-phase cultures were exposed to FGF-free media for 
various times from 30 min to 8 h, then refed growth medium, 
incubated another 20-30 h to permit cell fusion, and scored 
for clones containing myotubes. According to this assay ev- 
ery  myotube-positive colony must have contained  several 
commited cells that could not be prevented from fusing after 
FGF readdition. The results (Fig. 4) indicate a significant in- 
crease in myotube-positive colonies in cultures deprived of 
FGF for as little as 2 h, and with a 5-h deprivation all colo- 
nies exhibit fusion. The failure of FGF restoration to prevent 
the initiation of fusion  10-14 h  later (Fig.  3) indicates that 
FGF deprivation does, indeed,  induce an irreversible com- 
mitment event. The reason that all colonies were not myo- 
tube positive unless subjected to '~5 h of FGF deprivation 
is presumably due to cell cycle synchrony within individual 
small clones (i.e., some colonies had no G, phase cells dur- 
ing the first 3-4 h of FGF deprivation,  see below). 
FGF-deprived Myoblasts Commit to the Postmitotic 
State before Fusion 
The inability of FGF to prevent cells that are deprived of 
FGF for as little as 2-3 h from differentiating suggests that 
without this mitogen cells lose the ability to initiate DNA 
synthesis. To test for postmitotic cells and to determine the 
rate at which this phenotype is established, log-phase myo- 
blasts were switched to FGF-free medium for various inter- 
vals,  and  then  returned  to mitogen-rich medium.  After a 
12-h period to permit completion of DNA synthesis by any 
S-phase cells,  [3H]Tdr was added and the cultures were in- 
cubated an additional 20 h. After autoradiography the post- 
mitotic (unlabeled  cells) could then be distinguished  from 
the proliferative (labeled) cells. The kinetics of commitment 
to a postmitotic phenotype are shown in Fig. 5. Virtually all 
myoblasts remained proliferative in  the  presence of FGE 
Postmitotic  cells,  however,  appeared within  2  h  after ex- 
posure to 5 % HS, and the entire population was postmitotic 
by  14 h.  The rate at which cells became postmitotic when 
switched to FIOC+ 15 % HS was slightly slower and the final 
percentage again was lower than in 5 % serum. However, in 
either serum concentration,  FGF-deprived myoblasts com- 
mitted to a  postmitotic phenotype at essentially the  same 
time that they started to withdraw from the cell cycle (Fig. 
lOO 
N  ao 
'<  60 
Z 
o 
u.  40 
,,1- 
I,- 
~  20 
Z  o 
~  o 
1  I  I  O 
0  2  4  6  8 
HOURS  OF  MITOGEN  DEPRIVATION 
Figure 4.  Commitment  to fusion after FGF deprivation.  Clonal 
MM14 cultures  were grown exponentially  for 96 h, then  rinsed 
twice with F10C, and refed with FIOC +  15 % HS  +  FGF (t~), or 
switched to FGF-minus media (o) FIOC +  5%  HS; (e) FIOC + 
15 % HS. At the indicated times, cultures were refed with FIOC + 
15 % HS +  FGF; 22 h after the last refeeding point, cultures were 
fixed and analyzed for the percentage of clones with myotubes. To 
prevent depletion of FGF after its restoration,  cultures were refed 
with FGF at 12 and 24 h. For a colony to be scored as fused, it had 
to contain at least two multinucleated cells with a minimum of three 
nuclei/cell. Each data point represents an average from two experi- 
ments (two duplicate plates in each experiment with >100 clones 
per point). Standard deviations for each point were <10%. FGF lev- 
els in different experiments were  10 and 25 ng/ml (Collaborative 
Research,  Inc.). 
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Figure 5. Commitment to the postmitotic state after FGF depriva- 
tion.  Clonal  MMI4 cultures were grown exponentially for 60 h, 
then rinsed twice with FIOC, and refed with F10C +  15 % HS  + 
FGF (D), or switched to FGF-minus media (o) FIOC +  5% HS; 
(e) FIOC +  15% HS. At the indicated times, cultures were refed 
with F10C +  15 % +  FGF. The assay for postmitotic cells was per- 
formed as described in Materials and Methods. Each data point is 
an average from three experiments (90 clones total) and unless indi- 
cated by error bars the standard deviation was <5 %. The dashed 
line represents the theoretical percentage of postmitotic ceils, as- 
suming all G1 cells become committed.  It is based on the follow- 
ing assumptions:  (a)  exponential  growth with  12.5-h population 
doubling; (b) G~ phase lasts 2 h and thus contains 21% (see below) 
of the total cell population; (c) cells commit to the postmitotic state 
only in G~ phase;  (d) after FGF removal, a 2-h lag phase occurs 
before  any cells  commit;  (e) after the  lag,  all cells entering  G~ 
commit. At time 0 the fraction of cells in G~ is calculated by in- 
tegrating  over the 0-2-h interval of a  12.5-h exponential growth 
curve. At any time after the 2-h lag the fraction of cells in the G~ 
compartment is calculated by integrating the area represented by the 
expanding  G1 compartment (e.g., 0-3 h, 0-4 h, etc.) beneath  a 
12.5-h exponential growth curve (37, 41). 
2) and started committing to fusion (Fig. 4). Further proof 
that the postmitotic state, as assayed above, represents a per- 
manent withdrawal from the cell cycle, and not simply a long 
lag period for reinitiating DNA synthesis, was obtained with 
a colony-formation assay that examined the proliferative ca- 
pacity of cells for 4  d  (see Fig.  6). 
Commitment to the Postmitotic State, to Expression 
of  Muscle-specific  Genes, and to Fusion Occurs with 
Identical Kinetics 
The concomitant commitment of MM14 myoblasts to both 
the  postmitotic  state  and  fusion  suggests  that  the  major 
phenotypes of skeletal muscle are initiated by a single FGF- 
regulated event. If this were so. FGF-deprived cells should 
commit to the expression of muscle-specific genes with the 
same kinetics. As shown in Fig. 6, MM14 myoblasts commit 
to an AChR-positive phenotype after the same lag period ob- 
served for the other muscle parameters (Figs. 4 and 5); and 
once initiated, the population kinetics of commitment to the 
expression of AChR is virtually identical to the kinetics for 
commitment to the postmitotic state. This observation is con- 
sistent with the suggestion that FGF represses a single regu- 
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Figure 6. Comparison of the kinetics of commitment to the expres- 
sion of a muscle-specific gene with the kinetics of commitment to 
the postmitotic state. Clonal MM14 cultures were grown exponen- 
tially for 60 h, then rinsed twice with F10C, and switched to FGF- 
depleted medium. At the indicated times, cultures were refed with 
growth  medium  and  then  subsequently  assayed as described  in 
Materials and Methods.  (o) Percentage of postmitotic cells as de- 
termined by failure to incorporate [3H]Tdr; ([]) percentage of post- 
mitotic cells as determined by the loss of colony-forming ability; 
(zx) percentage of cells that committed to AChR expression ([t25I] 
ct-bungarotoxin binding at 24 h). Data points represent >200 cells 
counted for the labeled cell assays and '~250 clones for the colony- 
formation assay. 
latory event which, after FGF removal, activates the terminal 
differentiation phenotype. 
Mitogen Regulation of  DNA Synthesis and Terminal 
Differentiation Occurs Exclusively during GI 
Our results suggest that FGF regulation of both DNA synthe- 
sis and terminal differentiation occurs during the G1 phase 
of the  cell  cycle.  To demonstrate this  unambiguously  we 
exposed mitotically  synchronized  cultures  to  either  mito- 
ten-rich or mitogen-depleted medium plus [3H]Tdr. After a 
24-h incubation period, cultures were processed for detec- 
tion  of DNA  synthesis  and  MHC  protein  (Table I).  The 
results indicate that as myoblasts enter Gt in the presence of 
FGF they replicate DNA and remain MHC negative, where- 
as in the absence of FGF they differentiate before initiating a 
new cell cycle. Clearly, DNA replication and the onset of ter- 
minal muscle differentiation are both regulated by mitogenic 
signals initiated in Gt. Even when the cell has traversed the 
previous cell cycle and entered mitosis in the presence of 
FGE  the  absence of FGF  in G~  leads  to rapid differenti- 
ation. 
While  this experiment demonstrates a  G~  phase regula- 
tion of terminal differentiation, it does not indicate whether 
S or G2 phase cells would also be induced to commit when 
exposed to FGF-free medium. If commitment occurs exclu- 
sively in  G~,  then the percentage of postmitotic cells per 
clone should be equal to or less than the number of cells that 
accumulate in G~ during the final population doubling.  Al- 
ternatively, if FGF-deprived S and G2 phase cells also com- 
mit to differentiation, the total number of postmitotic cells 
would be augmented by the daughter cells of parental myo- 
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and Terminal Differentiation during the G1 Phase 
of  the Myoblast Cell Cycle 
Cells 
Medium composition*  Replicating DNAt  Differentiated  cells§ 
15%  HS  +  EEII  98  1 
15%  HS  +  FGF¶  96  3 
15%  HS  20  80 
5%  HS  1  98 
The data are averages of two experiments in which a minimum of 500 cells was 
scored in each medium tested. 
* Mitotic cells were plated into the indicated media containing  [3HlTdr (1.0 
IxCi/ml) and incubated for 24 h. Plates were then fixed, immunostained for my- 
osin detection,  and  processed  for autoradiographic  detection  of 3H-labeled 
nuclei. 
~: The percentage of cells  replicating DNA was determined by autoradiogra- 
phy. Since MM14 cells have a 12.5-h ceU cycle and since the cells used in the 
experiment were mitotically synchronized (i.e.,  entered G~ shortly after plat- 
ing), it was assumed that each labeled cell detected 24 h after plating had com- 
pleted one additional cell cycle, whereas unlabeled cells had remained in a Gl 
or Go phase  throughout  the  24-h period.  For 500 total  cells  of which 490 
were  [3H]Tdr positive,  the  percentage  of the  original  Gl  cells  replicating 
DNA was:  (490/2)/[(490/2)  +  10l  x  100%  =  96%. 
§ Differentiated cells were scored on the basis of being postmitotic (failure to 
incorporate  rH]Tdr) and positive staining for MHC.  In accordance with the 
explanation given above, the percent of the original Gl cells that differentiated 
was calculated as follows. For 500 total cells of which 330 were both unlabeled 
and MHC-positive: percentage of differentiated cells was: 330/[330  + (170/2)] 
x  100%  =  80%. 
II EE  =  3 % chick embryo extract. 
¶ 10 ng/ml FGF (Collaborative Research,  Inc.). 
blasts that had committed in S  or G2.  The theoretical ac- 
cumulation of cells in G~ was calculated (37, 41) and com- 
pared with the actual increase in postmitotic cells after FGF 
removal (Fig. 5). As indicated, the percentage of postmitotic 
cells  never exceeds the calculated percentage of G1  cells 
(Fig. 5, dashed line) that accumulate during cell cycle with- 
drawal. After 3 h in medium containing 5 % serum, about 
half of the G~  population can reenter the cell cycle after 
FGF readdition. Thereafter, the increase in postmitotic cells 
matches the accumulation of cells in Gj. Although cells fed 
15 % serum withdraw from the cell cycle at the same rate as 
cultures fed 5 % serum (Fig. 2), fewer cells become postmi- 
totic per unit time. These data suggest that commitment to 
terminal differentiation in response to FGF removal occurs 
only after cells have completed the cell cycle and entered 
Gl. 
FGF  Represses Commitment Independently of 
Ongoing Cell Replication 
FGF mediates two events in Gj myoblasts: it stimulates cell 
replication  and  represses  terminal  differentiation.  Is  the 
FGF-mediated repression of terminal differentiation simply 
an "indirect" consequence of mitogenesis, or is there a "di- 
rect" repression mechanism that is independent of cell repli- 
cation? These alternatives could be distinguished by taking 
advantage of the fact that MM14 cell proliferation requires 
both serum and FGE Cultures could thus be exposed to FGF 
in the absence of serum (and proliferation) and be assayed 
for repression of terminal differentiation (Table II). In this 
experiment control cultures fed FGF and serum continued 
to replicate; clones doubled nearly twice with a high percent- 
age of cells still replicating DNA after 24 h,  and MHC- 
positive cells were  absent.  Not surprisingly, cultures de- 
prived of FGF and serum completed one cell cycle and then 
differentiated. Interestingly, while cells exposed to FGF but 
no serum failed to replicate beyond a single doubling (only 
6% of the cells were synthesizing DNA after 24 h), <10% 
of the cells became MHC positive and postmitotic. This re- 
sponse demonstrates that myoblasts can "stop" cycling in G1 
without differentiating or committing to the postmitotic phe- 
notype.  Thus,  the repression of muscle differentiation by 
FGF occurs independently of cell proliferation. 
Discussion 
The principles of MM14 behavior after FGF removal typify 
those of most myoblast types adapted to tissue culture. It has 
been recognized for some time that differentiation is inhib- 
ited by factors present in serum and embryo extract, and that 
crude FGF preparations repress the differentiation of myo- 
blasts isolated from a variety of sources (1, 10, 14, 18, 19, 23, 
27). The observation that G~-phase MM14 myoblasts are not 
obligated to replicate DNA before differentiation is unusual 
compared with most mitogen-deprived myoblasts that un- 
dergo additional rounds of DNA synthesis. This behavior is, 
however,  consistent with previous studies using DNA syn- 
thesis inhibitors which indicated that additional DNA syn- 
thesis was not required after mitogen deprivation (9, 33).  It 
is also consistent with some previous experiments with quail 
and rat myoblasts that had been switched to totally defined 
mitogen-free medium (11, 38). 
FGF-deprived MM14 cells exhibit a"simultaneous" activa- 
tion of terminal differentiation pathways leading to the post- 
mitotic state,  expression of muscle-specific genes, and fu- 
sion.  The observation that these phenotypes occur  in  an 
ordered sequence does not imply a causal dependence among 
them.  In fact,  ~1%  of mitotically synchronized FGF-de- 
prived MM14 cells accumulate detectable levels of muscle 
gene products without being postmitotic (data not shown). 
This observation is consistent with the behavior of other 
skeletal muscle systems (8,  12, 23, 24, 32, 34); but in these 
cases  a  much  larger  percentage  of the  mitogen-deprived 
population can express muscle genes without becoming post- 
mitotic. Muscle gene expression is thus not dependent upon 
a cell's prior acquisition of a postmitotic state. 
The dependence of the postmitotic state on fusion remains 
controversial. In FGF-deprived MM14 cultures 75 % of the 
cells are postmitotic before fusion begins. Similar behavior 
has been reported for other myoblasts (3, 33, 40, 42). In con- 
trast, mitogen-deprived quail myoblasts activate myosin ex- 
pression, and enter a prolonged G~ or Go phase from which 
they can resume proliferation when mitogens are restored 
(8). This behavior may, however, be due to secondary effects 
of using EGTA to block cell fusion. (For example, see refer- 
ences 12, 20, 33 for conflicting data as to Ca  ++ effects on rat 
L6 myoblast differentiation.) It may also be relevant to note 
that external Ca  ~  is required for FGF-mediated mitogene- 
sis (30). 
It would be misleading to suggest that the differentiation 
of all myoblast types is regulated identically to MM14. For 
instance, the mouse line C2C12 which has FGF receptors 
does not require FGF for growth; and some sublines of the 
rat L6 have few, if any, FGF receptors and are unresponsive 
to FGF (Olwin,  B.  B.,  and S.  D.  Hauschka, unpublished 
data). The terminal differentiation of L6 myoblasts is, how- 
The Journal of Cell Biology, Volume  105, 1987  954 Table II. FGF Prevents Differentiation in Noncycling  GI Cells 
Medium composition  Parameter assayed 
FGF~  t  Serum§  Clonal doublings  S-phase cells  MHC-positive cells  Postmitotic ceils 
n  %  %  % 
+  +  1.7  53  0  0 
--  --  0.8  0.5  93  99 
+  -  0.9  6  8  8 
Clones that were established in media containing 10 ng/ml FGF plus 15% HS were rinsed twice with F10C and switched to the three test media. 24 h later, the 
percentage of cells expressing each phenotype was determined. At least 30 clones and >500 cells were counted for each determination. 
* All media contained FIOC and were supplemented with 1 ttM insulin to prevent the toxic effect of protein-free medium. 
~; Plus or minus 10 ng/ml FGF (Collaborative Research, Inc.). 
§ Plus or minus 15%  HS. 
ever, regulated by insulin-like growth factors (13). It is also 
possible that the inhibition of differentiation in some muscle 
lines that is caused by serum may be due to the presence of 
transforming growth factor-I~, which is known to inhibit ter- 
minal muscle differentiation (31, 35). In addition, it is possi- 
ble, as proposed by stem-cell lineage models, that certain 
myoblasts that differentiate in the presence of mitogens are 
regulated by an intrinsic "probabilistic clock" (39).  Alterna- 
tively, these myoblasts may undergo several additional cell 
cycles after being triggered to differentiate by mitogen depri- 
vation. While it is clear that FGF is not the only mitogen to 
which myoblasts respond,  it is important to reiterate that 
FGF is essential for many myoblast types and that FGF is 
present in both adult (18, 19) and embryonic chick muscle 
and early limb bud tissue (Seed, J., and S. D. Hauschka, un- 
published data). 
The molecular events involved in a cell becoming post- 
mitotic are not understood, but two studies have provided 
instructive  dues.  First,  heterokaryon  analyses  involving 
MM14 argue that myocytes contain a diffusible factor that in- 
hibits intracellular mitogenic signals (7).  Second, studies of 
mitogen receptor behavior indicate that commitment to ter- 
minal differentiation is accompanied by the permanent loss 
of  both epidermal and fibroblast growth factor receptors (25; 
Olwin, B. B., and S. D. Hauschka, unpublished data). The 
postmitotic state might thus be initiated by the production of 
a diffusible inhibitor of mitogenesis, and then made perma- 
nent by the irreversible loss of mitogen receptors. 
The model supplemented by our studies suggests that my- 
oblasts proliferate indefinitely until they encounter insuffi- 
cient levels of one or more specific growth factors. They then 
commit irreversibly to terminal differentiation, become post- 
mitotic, express muscle-specific genes, and fuse. The control 
of commitment is deceptively simple in vitro where a ho- 
mogeneous muscle population is instantaneously deprived of 
a  single  required  growth  factor.  In  vivo,  where  muscle 
differentiation lasts over periods of days to years, the regula- 
tion must be more complex. Within a single developing mus- 
cle, there is almost certainly a diversity of myoblast types 
with different mitogen sensitivities.  The mechanisms respon- 
sible for regulating the relative populations of cells and mito- 
gen levels within microenvironments of  the developing tissue 
remain to be determined. 
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